How RNA molecules influence the development of aggressive leukemia
· Medical Xpressby CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences
edited by Gaby Clark, reviewed by Robert Egan
Gaby Clark
Scientific Editor
Meet our editorial team
Behind our editorial process
Robert Egan
Senior Editor
Meet our editorial team
Behind our editorial process Editors' notes
This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:
fact-checked
peer-reviewed publication
trusted source
proofread
The GIST Add to Preferred Sources
Researchers at the University of Veterinary Medicine Vienna, in collaboration with the CeMM Research Center for Molecular Medicine and St. Anna Children's Cancer Research, have developed a new analytical method that reveals which RNA molecules are involved in cancer-promoting cellular structures. Using this method, the Vienna-based research team identified the RNA molecule Gas5 as an important regulator of NUP98::KDM5A oncogenic condensates, which control gene activity in aggressive forms of acute myeloid leukemia (AML). This new insight may provide important starting points for cancer research and improved patient treatment. The study was published in the journal The EMBO Journal.
Aggressive leukemias can be driven by so-called fusion oncoproteins. Within cells, these proteins can accumulate in biomolecular condensates—dynamic, membrane-less structures in which different biomolecules interact to influence gene activity. Until now, however, little was known about which RNA molecules are involved in these "oncocondensates."
"With the bicon-seq method we have developed, we can now systematically identify which RNAs are associated with biomolecular condensates. This makes a previously difficult-to-access layer of gene regulation measurable," explains Florian Grebien, senior author of the study and head of the Unit of Medical Biochemistry at the University of Veterinary Medicine Vienna.
A central research focus: RNA as a component of oncocondensates
The current study focused on the fusion oncoprotein NUP98::KDM5A. This protein occurs in aggressive forms of AML and promotes the formation of condensates in leukemia cells that are required for the activation of leukemia-relevant genes.
The new bicon-seq analytical method provides quantitative information on the cellular solubility of RNA molecules. According to the researchers, changes in this parameter indicate whether an RNA is more strongly or more weakly associated with biomolecular condensates. "Importantly, this approach does not merely provide a snapshot. We can track how the RNA composition of condensates changes when key components are specifically disrupted or depleted," says Melanie Allram, first author of the study.
The lncRNA Gas5 plays a key role in leukemia cell proliferation
The analyses identified several long noncoding RNAs (lncRNAs) associated with NUP98::KDM5A oncocondensates. The lncRNA Gas5 was particularly notable: it was highly expressed in AML cells, co-localized with NUP98::KDM5A in condensates and proved to be important for the proliferation of leukemia cells.
When Gas5 was specifically downregulated using CRISPRi—a method for targeted suppression of gene expression—the gene activity of AML cells changed substantially. Among the affected genes were those involved in differentiation and programmed cell death. "This shows that the Gas5 lncRNA is not only a component of these condensates, but can also influence their function," emphasizes Allram.
A new method for investigating the RNA biology of condensates
The study describes a new experimental approach for investigating biomolecular condensates. Grebien explains: "bicon-seq enables us to quantitatively characterize the RNA composition of these structures under both normal and perturbed conditions. This opens up new opportunities to investigate the role of RNAs in regulating disease-relevant condensates."
The findings underscore the importance of noncoding RNAs for the function of fusion oncoproteins. Further studies by the Grebien Lab will now examine in greater detail how the interaction between Gas5 and the NUP98::KDM5A fusion protein affects gene activity and leukemia development.
Publication details
Allram, M. et al. The EMBO Journal (2026). DOI: 10.1038/s44318-026-00926-6, link.springer.com/article/10.1 … 8/s44318-026-00926-6
Journal information: EMBO Journal
Key medical concepts
Clinical categories
OncologyLaboratory medicine Provided by CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences Who's behind this story?
Gaby Clark
MA in English, copy editor since 2021 with experience in higher education and health content. Dedicated to trustworthy science news. Full profile →
Robert Egan
Bachelor's in mathematical biology, Master's in creative writing. Well-traveled with unique perspectives on science and language. Full profile →
Citation: How RNA molecules influence the development of aggressive leukemia (2026, October 14) retrieved 14 October 2026 from https://medicalxpress.com/news/2026-10-rna-molecules-aggressive-leukemia.html This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.